The Role of Algae in a Modern UK Diet
Algae are not a traditional part of the British diet. You will not find chlorella in a Sunday roast or marine phytoplankton in a full English.
But the nutritional gaps in a modern UK diet, particularly for people reducing or eliminating animal products, create a practical case for algae-derived ingredients that did not exist a generation ago. The question is not whether algae is part of your food culture. It is whether it fills gaps your current diet leaves open.
We reviewed NDNS dietary intake surveys, published UK vegan nutrition research, and our own customer intake patterns to map where the gaps are largest and how consistently algae-derived nutrients address them. What emerged was sharper than we expected.
The Nutritional Gaps Algae Fill in UK Diets
Omega-3 EPA and DHA: the UK population's average intake of long-chain omega-3 falls below the level associated with the EFSA heart-function claim (250 mg combined EPA+DHA daily, EU 432/2012). For the roughly 3% of the UK population that is vegan, and the larger proportion that simply does not eat oily fish regularly, the shortfall is wider.
Fish is the conventional solution. If you do not eat fish, algae-derived EPA and DHA are the direct plant-based alternatives. We covered the sourcing options in our plant-based omega-3 guide.
Micronutrient diversity. Modern UK diets, even well-intentioned ones, tend toward a narrow range of vegetables and grains. Algae like chlorella and phytoplankton deliver a nutrient spectrum that includes chlorophyll, carotenoids, amino acids, and trace minerals in concentrations not available from common UK supermarket produce. This is not a criticism of your diet. It is a characteristic of what is commercially available and practically convenient in the UK food system.
B12 for plant-based diets. The UK's growing vegan and vegetarian population faces a well-documented B12 challenge. Some algae contain B12, though the bioavailability varies by strain. Algae are not a reliable sole source of B12 until strain-specific data improves, but they can contribute to a broader supplementation strategy alongside a dedicated B12 supplement.
How Algae Fits Into a UK Diet
The practical integration is simpler than it sounds. You are not being asked to eat seaweed salad for lunch. The common formats are:
Phytoplankton powder. One to two teaspoons stirred into water, juice, or a smoothie in the morning. Provides EPA, chlorophyll, carotenoids, and micronutrients. The taste is mildly marine. It takes thirty seconds.
Chlorella tablets or powder. Three to five grams daily, either as tablets swallowed with water or powder mixed into food. Provides protein, chlorophyll, iron, B vitamins. The taste of the powder is earthy and green.
Algae DHA capsules. One capsule daily, no taste. Provides DHA for brain function, vision, and heart health alongside EPA from other sources.
Greens powder blends. A single product combining multiple algae and plant ingredients. Convenient if you want broad coverage without multiple separate supplements. Check the individual ingredient quantities rather than relying on the blend name. We compared greens powders vs multivitamins and greens powders vs vegetables in separate articles.
Who Benefits Most
- Vegans and vegetarians who need 250 mg EPA+DHA daily (a threshold practically unreachable from plant sources other than algae) alongside B12 and broad-spectrum micronutrient cover without animal products
- People who do not eat oily fish regularly (roughly 75 per cent of UK adults averaging under 56 g oily fish per week), who fall below the EFSA-linked intake threshold by default, regardless of their dietary label
- People looking to consolidate supplements by replacing fish oil, a separate B12, and a greens capsule with one or two whole-food algae products
- Athletes and active people interested in the directionally positive research on phytoplankton and exercise recovery; Sharp et al. 2020 found reduced muscle damage markers across repeated bouts
- Pregnant and breastfeeding women on plant-based diets who need DHA for foetal and infant development and have no reliable fish-sourced route to it
Who Does Not Need Algae Supplements
If you eat oily fish twice a week, have a varied diet rich in vegetables, and have no diagnosed nutrient deficiencies, algae supplements may add marginal value rather than transformative value. The honest case for algae is strongest where there is a clear nutritional shortfall to address.
If your diet is already covering the bases, the additional benefit is incremental.
We sell these products and we are still telling you this, because recommending a supplement to someone who does not need it is a credibility liability, not a sales opportunity.
The UK Context Specifically
The UK's food and supplement regulatory environment recognises algae-derived omega-3 as equivalent to fish-derived omega-3 for the purposes of health claims. The EFSA-authorised claims for EPA and DHA apply regardless of source under retained EU law. UK retailers stock algae supplements alongside fish oil, and consumer awareness of algae-based alternatives has grown substantially in the past five years.
The UK also has one of the fastest-growing plant-based food markets in Europe, which means the potential audience for algae-derived nutrition is expanding. We grow our phytoplankton in controlled environments and think the UK market is well-positioned to value the transparency and purity advantages that come with that approach.
What our research found
The UK omega-3 shortfall shaped what we built first. NDNS data shows UK adults average 56 g oily fish per week against a recommended 140 g. Only a quarter of UK adults are regular oily fish consumers. Among 20 to 29 year-olds, just 15.6 per cent meet the recommendation.
When we were deciding which nutrient to lead with in our phytoplankton formulation, this gap was the clearest signal: EPA from algae, not ALA conversion, is what the UK market actually needs.
B12 deficiency among UK vegans is higher than often quoted — and algae does not fix it. Published UK data found 52 per cent of male vegans had plasma B12 below the level where neurological symptoms can develop. Hospital admissions for B12 deficiency anaemia in England rose to over 38,000 in 2023-24.
This is why we do not market our algae products as B12 solutions: the pseudocobalamin problem in spirulina and chlorella means the label figure and the bioavailable figure are often different numbers, and for a deficiency this serious, that gap matters.
Why we manufacture EPA and DHA as separate products, not a combined capsule. No single algae species delivers both fatty acids at useful doses. Nannochloropsis gives you EPA. Schizochytrium gives you DHA.
Combined capsules are genuinely more convenient for someone who has decided their EPA:DHA ratio in advance. When we formulated for the UK market, we decided against blending because it would lock customers into a fixed ratio that suits neither someone switching from fish oil nor someone who already takes DHA and only needs EPA top-up. The separate-product structure is a deliberate formulation choice, not a product line decision.
Sources
- Commission Regulation (EU) No 432/2012 establishing a list of permitted health claims made on foods. Official Journal of the European Union. 2012;L136:1-40. EUR-Lex
- Burdge GC, Calder PC. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev. 2005;45(5):581-597. PubMed
- Watanabe F et al. Characterization and bioavailability of vitamin B12-compounds from edible algae. J Nutr Sci Vitaminol. 2002;48(5):325-331. PubMed
- Sharp M et al. Phytoplankton Supplementation Lowers Muscle Damage and Sustains Performance across Repeated Exercise Bouts in Humans. Nutrients. 2020;12(7):1990. PubMed
Cara Hayes, MSc Nutrition and Dietetics (University of Sydney), writes all content in the Phytality Knowledge Centre. Read our editorial policy.
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Consult your healthcare provider before starting any supplement.
Methodology and Disclosure
Phytality manufactures algae-based supplements for the UK market. We have a commercial interest in algae supplementation being valued in the UK diet. UK omega-3 intake data reflects published dietary surveys. The 3% vegan population figure is an approximate estimate from UK survey data.
EFSA health claims are from Commission Regulation (EU) No 432/2012, applicable in GB under retained EU law. UK market growth observations reflect published market research. This article does not cite specific dietary surveys by name, and the general patterns described are consistent across multiple UK nutrition surveys.
Last reviewed: March 2026
